サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1582711

陽子線治療システムの世界市場：産業分析、規模、シェア、成長、動向、予測（2024年～2031年）

Proton Therapy Systems Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2031
出版日: | 発行: Persistence Market Research | ページ情報: 英文 116 Pages | 納期: 2～5営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=150.96円
陽子線治療システムの世界市場：産業分析、規模、シェア、成長、動向、予測（2024年～2031年）
出版日: 2024年10月31日
発行: Persistence Market Research
ページ情報: 英文 116 Pages
納期: 2～5営業日
  • 全表示
  • 概要
  • 目次
概要

当レポートでは、世界の陽子線治療システム市場について調査分析し、市場の促進要因、動向、機会、促進要因、課題などの重要な市場力学の評価や、市場構造に関する詳細な見識を提供しています。

目次

第1章 エグゼクティブサマリー

第2章 市場のイントロダクション

第3章 世界の陽子線治療市場の分析シナリオ

  • 市場と予測
    • 市場規模と前年比成長

第4章 市場力学

  • 経済的要因
  • 促進要因
    • サプライサイド
    • デマンドサイド
  • 抑制要因
  • 機会
  • 稼働台数データ
  • 世界のがん有病率

第5章 世界の陽子線治療市場の分析と予測：セットアップタイプ別

  • イントロダクション
  • ベーシスポイントシェア（BPS）分析：セットアップタイプ別
  • 前年比成長予測：セットアップタイプ別
  • 市場金額の予測：セットアップタイプ別
    • シングルルーム
    • マルチルーム
  • 市場の魅力：セットアップタイプ別

第6章 世界の陽子線治療市場の分析と予測：適応症別

  • イントロダクション
  • ベーシスポイントシェア（BPS）分析：適応症別
  • 前年比成長予測：適応症別
  • 市場金額の予測：適応症別
    • 頭頸部がん
    • 脳腫瘍
    • 肉腫
    • 小児がん
    • 消化器がん
    • 前立腺がん
    • 肺がん
  • 市場の魅力：適応症別

第7章 世界の陽子線治療市場の分析と予測：地域別

  • ベーシスポイントシェア（BPS）分析：地域別
  • 前年比成長予測：地域別
  • 市場金額の予測：地域別
    • 北米
    • 欧州
    • アジア太平洋
    • 中東・アフリカ
  • 市場の魅力：地域別

第8章 北米の陽子線治療市場の分析と予測

  • イントロダクション
    • ベーシスポイントシェア（BPS）分析：国別
    • 前年比成長予測：国別
  • 市場金額の予測：セットアップタイプ別
    • シングルルーム
    • マルチルーム
  • 市場金額の予測：適応症別
    • 頭頸部がん
    • 脳腫瘍
    • 肉腫
    • 小児がん
    • 消化器がん
    • 前立腺がん
    • 肺がん
  • 市場金額の予測：国別
    • 米国
  • 市場の魅力分析
    • セットアップタイプ別
    • 適応症別

第9章 欧州の陽子線治療市場の分析と予測

  • イントロダクション
    • ベーシスポイントシェア（BPS）分析：国別
    • 前年比成長予測：国別
  • 市場金額の予測：セットアップタイプ別
    • シングルルーム
    • マルチルーム
  • 市場金額の予測：適応症別
    • 頭頸部がん
    • 脳腫瘍
    • 肉腫
    • 小児がん
    • 消化器がん
    • 前立腺がん
    • 肺がん
  • 市場金額の予測：国別
    • プラハ
    • フランス
    • スイス
    • イタリア
    • ドイツ
    • 英国
    • スウェーデン
    • ロシア
  • 市場の魅力分析
    • セットアップタイプ別
    • 適応症別
    • 国別

第10章 アジア太平洋の陽子線治療市場の分析と予測

  • イントロダクション
    • ベーシスポイントシェア（BPS）分析：国別
    • 前年比成長予測：国別
  • 市場金額の予測：セットアップタイプ別
    • シングルルーム
    • マルチルーム
  • 市場金額の予測：適応症別
    • 頭頸部がん
    • 脳腫瘍
    • 肉腫
    • 小児がん
    • 消化器がん
    • 前立腺がん
    • 肺がん
  • 市場金額の予測：国別
    • 中国
    • 日本
    • 韓国
  • 市場の魅力分析
    • セットアップタイプ別
    • 適応症別
    • 国別

第11章 中東・アフリカの陽子線治療市場の分析と予測

  • イントロダクション
    • ベーシスポイントシェア（BPS）分析
    • 前年比成長予測
  • 市場金額の予測：セットアップタイプ別
    • シングルルーム
    • マルチルーム
  • 市場金額の予測：適応症別
    • 頭頸部がん
    • 脳腫瘍
    • 肉腫
    • 小児がん
    • 消化器がん
    • 前立腺がん
    • 肺がん
  • 市場金額の予測：国別
    • 南アフリカ
  • 市場の魅力分析
    • セットアップタイプ別
    • 適応症別

第12章 競合情勢

  • 競合ダッシュボード
  • 企業プロファイル（詳細 - 概要、財務、戦略、近年の動向）
    • Hitachi Ltd.
    • Ion Beam Applications SA
    • Mevion Medical Systems
    • Mitsubishi Electric Corporation
    • ProNova Solutions, LLC
    • ProTom International
    • Sumitomo Heavy Industries Ltd.
    • Varian Medical Systems

第13章 使用される前提条件と頭字語

第14章 調査手法

目次
Product Code: PMRREP12358

Persistence Market Research has recently released a comprehensive report on the global Proton Therapy Systems market. This report provides an in-depth evaluation of critical market dynamics, including drivers, trends, opportunities, and challenges, delivering detailed insights into the market structure.

Key Insights:

  • Proton Therapy Systems Market Size (2024E): USD 719.7 Mn
  • Projected Market Value (2031F): USD 1581.1 Mn
  • Global Market Growth Rate (CAGR 2024 to 2031): 11.9%

Proton Therapy Systems Market - Report Scope:

Proton Therapy is an advanced form of radiation therapy used primarily in the treatment of cancer. It uses protons rather than X-rays to target tumors with precision, minimizing damage to surrounding healthy tissues. This technology is especially beneficial for treating complex cancer cases, including pediatric cancers and tumors located in sensitive areas. The Proton Therapy Systems market includes healthcare facilities, research institutes, and specialized cancer treatment centers globally. Market growth is driven by the rising prevalence of cancer, increasing adoption of advanced radiation therapy techniques, and a growing emphasis on personalized treatment approaches.

Market Growth Drivers:

The global Proton Therapy Systems market is driven by a range of critical factors. Rising incidences of cancer worldwide, coupled with the increasing focus on personalized healthcare, have heightened the demand for precision treatment solutions like proton therapy. As proton therapy significantly reduces the risk of radiation exposure to non-cancerous tissues, it is favored for treating pediatric cancers and complex cases involving sensitive organs. Government initiatives and funding for cancer research, along with advancements in proton therapy technology, such as pencil-beam scanning, enhance treatment precision and widen the applicability of these systems. Furthermore, the expansion of healthcare infrastructure in emerging economies has contributed to increased accessibility and demand for proton therapy systems.

Market Restraints:

Despite promising growth prospects, the Proton Therapy Systems market faces significant challenges. High initial investment costs and the requirement for specialized infrastructure limit the adoption of proton therapy, particularly in low-income regions. The costs associated with building and maintaining proton therapy facilities, including equipment and specialized personnel, create financial barriers for many hospitals. Additionally, the limited number of clinical studies and long treatment times restrict the market's ability to fully penetrate the healthcare industry. Insurance reimbursement policies and varying regulatory standards across regions also pose challenges for market players, requiring strategic investment in educational outreach and policy advocacy.

Market Opportunities:

The Proton Therapy Systems market offers substantial opportunities for growth, driven by ongoing technological advancements, rising demand for minimally invasive treatments, and increasing support for cancer research. With the development of compact and more affordable proton therapy units, smaller healthcare providers can potentially integrate this technology, broadening the market's reach. The growing prevalence of pediatric cancers and other complex tumors opens new avenues for proton therapy, as it minimizes adverse effects. Additionally, partnerships between hospitals, research institutions, and technology firms can support new applications of proton therapy, allowing for its use in more diversified clinical settings. As emerging markets strengthen their healthcare infrastructure, investment in proton therapy systems presents an opportunity for companies aiming to expand their presence globally.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the Proton Therapy Systems market globally?
  • Which cancer types are most commonly treated with Proton Therapy Systems?
  • How are technological advancements influencing the competitive landscape of the Proton Therapy Systems market?
  • Who are the key players in the Proton Therapy Systems market, and what strategies are they employing to stay competitive?
  • What are the emerging trends and future prospects in the global Proton Therapy Systems market?

Competitive Intelligence and Business Strategy:

Leading players in the global Proton Therapy Systems market, including Varian Medical Systems, IBA Proton Therapy, and Mevion Medical Systems, are focusing on technological innovation, cost reduction, and strategic partnerships to enhance market share. These companies invest heavily in R&D to develop compact proton therapy systems that reduce costs and expand access. Collaborations with research institutions, hospitals, and government bodies foster greater adoption and accelerate clinical research in proton therapy. Key players also emphasize improving patient outcomes, sustainability, and quality standards, positioning them for strong market growth and enhanced consumer adoption of proton therapy solutions.

Key Companies Profiled:

  • Hitachi Ltd.
  • Ion Beam Applications SA
  • Mevion Medical Systems
  • Mitsubishi Electric Corporation
  • ProNova Solutions, LLC
  • ProTom International
  • Sumitomo Heavy Industries Ltd.
  • Varian Medical Systems
  • Others

Proton Therapy Systems Industry Segmentation:

By Set up Type

  • Single Room
  • Multiple Room

By Indication

  • Head and Neck Cancer
  • Brain Cancer
  • Sarcoma
  • Pediatric Cancer
  • Gastro-intestinal Cancer
  • Prostate Cancer
  • Lung Cancer

By Region

  • North America
  • Europe
  • Asia pacific
  • MEA

Table of Contents

1. Executive Summary

2. Market Introduction

  • 2.1. Market Definition
  • 2.2. Market Taxonomy

3. Global Proton Therapy Market Analysis Scenario

  • 3.1. Market Size (US$ Mn) and Forecast
    • 3.1.1. Market Size and Y-o-Y Growth
    • 3.1.2. Absolute $ Opportunity

4. Market Dynamics

  • 4.1. Economic Factors
  • 4.2. Drivers
    • 4.2.1. Supply Side
    • 4.2.2. Demand Side
  • 4.3. Restraints
  • 4.4. Opportunity
  • 4.5. Installed Base Data
  • 4.6. World Cancer Prevalence

5. Global Proton Therapy Market Analysis and Forecasts, By Set Up Type

  • 5.1. Introduction
  • 5.2. Basis Point Share (BPS) Analysis By Set Up Type
  • 5.3. Y-o-Y Growth Projections By Set Up Type
  • 5.4. Market Value Forecast By Set Up Type, 2024-2031
    • 5.4.1. Single Room
    • 5.4.2. Multiple Rooms
  • 5.5. Market Attractiveness By Set Up Type

6. Global Proton Therapy Market Analysis and Forecasts, By Indications

  • 6.1. Introduction
  • 6.2. Basis Point Share (BPS) Analysis By Indications
  • 6.3. Y-o-Y Growth Projections By Indications
  • 6.4. Market Value Forecast By Indications, 2024-2031
    • 6.4.1. Head & Neck Cancer
    • 6.4.2. Brain Cancer
    • 6.4.3. Sarcoma
    • 6.4.4. Pediatric Cancer
    • 6.4.5. Gastro-intestinal Cancer
    • 6.4.6. Prostate Cancer
    • 6.4.7. Lung Cancer
  • 6.5. Market Attractiveness By Indications

7. Global Proton Therapy Market Analysis and Forecasts, By Region

  • 7.1. Basis Point Share (BPS) Analysis By Region
  • 7.2. Y-o-Y Growth Projections By Region
  • 7.3. Market Value Forecast By Region
    • 7.3.1. North America
    • 7.3.2. Europe
    • 7.3.3. APAC
    • 7.3.4. MEA
  • 7.4. Market Attractiveness By Region

8. North America Proton Therapy Market Analysis and Forecast

  • 8.1. Introduction
    • 8.1.1. Basis Point Share (BPS) Analysis By Country
    • 8.1.2. Y-o-Y Growth Projections By Country
  • 8.2. Market Value Forecast By Set Up Type, 2024-2031
    • 8.2.1. Single Room
    • 8.2.2. Multiple Rooms
  • 8.3. Market Value Forecast By Indications, 2024-2031
    • 8.3.1. Head & Neck Cancer
    • 8.3.2. Brain Cancer
    • 8.3.3. Sarcoma
    • 8.3.4. Pediatric Cancer
    • 8.3.5. Gastro-intestinal Cancer
    • 8.3.6. Prostrate Cancer
    • 8.3.7. Lung Cancer
  • 8.4. Market Value Forecast By Country, 2024-2031
    • 8.4.1. US
  • 8.5. Market Attractiveness Analysis
    • 8.5.1. By Set Up Type
    • 8.5.2. By Indications

9. Europe Proton Therapy Market Analysis and Forecast

  • 9.1. Introduction
    • 9.1.1. Basis Point Share (BPS) Analysis By Country
    • 9.1.2. Y-o-Y Growth Projections By Country
  • 9.2. Market Value Forecast By Set Up Type, 2024-2031
    • 9.2.1. Single Room
    • 9.2.2. Multiple Rooms
  • 9.3. Market Value Forecast By Indications, 2024-2031
    • 9.3.1. Head & Neck Cancer
    • 9.3.2. Brain Cancer
    • 9.3.3. Sarcoma
    • 9.3.4. Pediatric Cancer
    • 9.3.5. Gastro-intestinal Cancer
    • 9.3.6. Prostrate Cancer
    • 9.3.7. Lung Cancer
  • 9.4. Market Value Forecast By Country, 2024-2031
    • 9.4.1. Prague
    • 9.4.2. France
    • 9.4.3. Switzerland
    • 9.4.4. Italy
    • 9.4.5. Germany
    • 9.4.6. U.K.
    • 9.4.7. Sweden
    • 9.4.8. Russia
  • 9.5. Market Attractiveness Analysis
    • 9.5.1. By Set Up Type
    • 9.5.2. By Indications
    • 9.5.3. By Country

10. APAC Proton Therapy Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Basis Point Share (BPS) Analysis By Country
    • 10.1.2. Y-o-Y Growth Projections By Country
  • 10.2. Market Value Forecast By Set Up Type, 2024-2031
    • 10.2.1. Single Room
    • 10.2.2. Multiple Rooms
  • 10.3. Market Value Forecast By Indications, 2024-2031
    • 10.3.1. Head & Neck Cancer
    • 10.3.2. Brain Cancer
    • 10.3.3. Sarcoma
    • 10.3.4. Pediatric Cancer
    • 10.3.5. Gastro-intestinal Cancer
    • 10.3.6. Prostate Cancer
    • 10.3.7. Lung Cancer
  • 10.4. Market Value Forecast By Country, 2024-2031
    • 10.4.1. China
    • 10.4.2. Japan
    • 10.4.3. South Korea
  • 10.5. Market Attractiveness Analysis
    • 10.5.1. By Set Up Type
    • 10.5.2. By Indications
    • 10.5.3. By Country

11. MEA Proton Therapy Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Basis Point Share (BPS) Analysis
    • 11.1.2. Y-o-Y Growth Projections
  • 11.2. Market Value Forecast By Set Up Type, 2024-2031
    • 11.2.1. Single Room
    • 11.2.2. Multiple Rooms
  • 11.3. Market Value Forecast By Indications, 2024-2031
    • 11.3.1. Head & Neck Cancer
    • 11.3.2. Brain Cancer
    • 11.3.3. Sarcoma
    • 11.3.4. Pediatric Cancer
    • 11.3.5. Gastro-intestinal Cancer
    • 11.3.6. Prostate Cancer
    • 11.3.7. Lung Cancer
  • 11.4. Market Value Forecast By Country, 2024-2031
    • 11.4.1. South Africa
  • 11.5. Market Attractiveness Analysis
    • 11.5.1. By Set Up Type
    • 11.5.2. By Indications

12. Competition Landscape

  • 12.1. Competition Dashboard
  • 12.2. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
    • 12.2.1. Hitachi Ltd.
    • 12.2.2. Ion Beam Applications SA
    • 12.2.3. Mevion Medical Systems
    • 12.2.4. Mitsubishi Electric Corporation
    • 12.2.5. ProNova Solutions, LLC
    • 12.2.6. ProTom International
    • 12.2.7. Sumitomo Heavy Industries Ltd.
    • 12.2.8. Varian Medical Systems

13. Assumptions and Acronyms Used

14. Research Methodology